Rudolf Maag (#597)
- $ 7 B
- Medical devices
- Switzerland
- M
- 80 Years
'A form of double taxation': Are management fees on new houses quietly getting out of control?
Trump Official Blames Biden Admin for Economic ‘Mess’ — As Resurfaced Clip Shows Him Saying Trump Would Own the Economy By 2026
Is Precigen, Inc. (PGEN) A Good Stock To Buy Now?
Is Transocean Ltd. (RIG) A Good Stock To Buy Now?
Tesla is selling Chinese-made cars in Canada to escape the tariffs that both China and America imposed on it
Insecurity didn’t start with Tinubu, group defends president’s security record
Vibrating pillow sleeve warns deaf sleepers of burglars and fires
How Kepler built verifiable AI for financial services with Claude
Is ASML Holding N.V. (ASML) A Good Stock To Buy Now?
5-Letter Words Ending in ‘Y’ to Help You Improve Your Wordle Skills
About Me
Rudolf Maag's fortune stems from medical devices. Maag got an M.B.A. from Insead in 1973 and began working his way up the corporate ladder at pharmaceutical company Sandoz AG of Switzerland. He later moved to dental giant Straumann, where in 1990 he bought out the medical device division and later took it public as Stratec Medical. In 1999 he merged Stratec with Swiss medical device powerhouse Synthes and built up a 15% stake, which was later sold to Johnson & Johnson.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Rudolf Maag’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Rudolf Maag’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $6.7B
(May 4, 2026)
© Iconic Billionaires